AGIO 93.04 Agios Pharmaceuticals Inc $AGIO Hit a 52 week

New Post Public Reply Private Reply Replies (0) Message Board

Nov 20, 2014 at 10:07 AM

AGIO 93.04 Agios Pharmaceuticals Inc $AGIO Hit a 52 week high of 95.79 Closing the day 09:45 at 93.04 -2.93 -3.05% With a day low of 92.47 and a total volume of 180,647.

AGIO Recent Posts: http://investorshangout.com/Agios-Pharmaceuti...GIO-90049/

AGIO Agios Pharmaceuticals Inc Recent Headline News

Agios Pharmaceuticals (AGIO) in Focus: Stock Rises 14.5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - 1 hr 16 mins ago
Agios Pharmaceuticals, Inc. (AGIO) was a big mover last session, as its shares rose roughly 15% on the day.
ICUI: 81.20 (-1.00), GWPH: 79.24 (+0.68), AGIO: 94.46 (-1.51), OSUR: 8.62 (-0.05)

Market Maker Surveillance Report. SSI, DL, EBR, TITXF, BODY, AGIO, Winning Stocks With Lowest Price Friction For Wednesday, November 19th 2014
M2 - Thu Nov 20, 3:42AM CST
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Wednesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Wednesday there were 4516 companies with "abnormal" market making, 1857 companies with positive Friction Factors and 3256 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage gain per share Wednesday and low price friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. STAGE STORES, INC. (NYSE:SSI), Danier Leather Inc (NYSE

L), Centrais Eletricas Brasileiras SA (NYSE:EBR), TITAN MEDICAL INC (OTC:TITXF), Body Central Corp (OTC:BODY), (NASDAQ:AGIO). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .
DL: 17.77 (+0.03), SSI: 19.11 (+0.32), EBR: 2.29 (-0.01), AGIO: 94.46 (-1.51)

Target and Lowe's are big market movers
AP - Wed Nov 19, 3:29PM CST
NEW YORK (AP) — Stocks that moved substantially or traded heavily Wednesday on the New York Stock Exchange and the Nasdaq Stock Market:
SPLS: 14.03 (+0.11), VIPS: 22.43 (-0.01), CLV: 7.85 (-0.11), TGT: 71.19 (-1.31), AGIO: 94.46 (-1.51), CLF: 8.04 (-0.13), OPLK: 24.17 (-0.01), DISH: 73.25 (-1.41)

Jim Cramer Explains Why Investors Win With Agios Pharmaceuticals (AGIO)
at The Street - Wed Nov 19, 1:11PM CST
TheStreet's Jim Cramer explains why investors in Agios Pharmaceuticals (AGIO) are winners and who could buy the $3 billion company.
AGIO: 94.46 (-1.51), CELG: 106.90 (-0.08)

Nasdaq stocks posting largest percentage increases
AP - Wed Nov 19, 12:31PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at 1 p.m.:
RESN: 8.31 (-0.43), CLUB: 6.25 (+0.18), SPLS: 14.03 (+0.11), FNHC: 25.53 (-0.70), AGIO: 94.46 (-1.51), OPLK: 24.17 (-0.01)

Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Wed Nov 19, 11:55AM CST

CLUB: 6.25 (+0.18), LEJU: 12.01 (-0.06), ANV: 1.66 (+0.17), SSI: 19.11 (+0.32), ROX: 1.76 (+0.08), CLF: 8.04 (-0.13), BIND: 8.25 (-0.15), NADL: 3.21 (+0.05), CSTM: 17.29 (-0.64), VRML: 1.45 (-0.05), WTT: 2.66 (+0.06), CANF: 3.59 (-0.23), DL: 17.77 (+0.03), BAMM: 1.84 (+0.19), RELV: 1.28 (+0.09), SNCR: 42.79 (+0.54), ATLC: 2.50 (-0.10), AGIO: 94.46 (-1.51), BBLU: 1.10 (-0.01), OPLK: 24.17 (-0.01)

Cramer: Agios Pharmaceuticals' Leukemia Drug Pushing Stock 'Much Higher'
at The Street - Wed Nov 19, 10:21AM CST
TheStreet's Jim Cramer says Agios Pharmaceuticals' positive Phase 1 data for its leukemia treatment is impressive. As a result, shares are going higher despite doubling since July.
AGIO: 94.46 (-1.51), CELG: 106.90 (-0.08)

Stock Futures Take A Data Dive; Tesla Falls On Outlook Change
at Investor's Business Daily - Wed Nov 19, 8:11AM CST
Stock futures fell out of flat trade to moderate losses ahead of Wednesday's open after a mixed read on October homebuilding activity. Dow futures slumped 18.8 points below fair market value. Nasdaq 100 futures traded down 6.3 points. S&P 500 futures...
SPLS: 14.03 (+0.11), LEJU: 12.01 (-0.06), TSLA: 249.37 (+1.63), FCAU: 12.17 (-0.06), LITB: 7.27 (-0.13), TTM: 46.39 (-0.31), DL: 17.77 (+0.03), VA: 34.08 (+0.87), TGT: 71.19 (-1.31), GM: 31.99 (-0.16), AGIO: 94.46 (-1.51), LOW: 62.44 (+0.18), HMC: 31.02 (-0.11), EJ: 8.67 (+0.15), PETM: 77.72 (-0.47)

Agios leukemia drug candidate shows clinical activity in Phase 1 trial
Seeking Alpha - at Seeking Alpha - Wed Nov 19, 8:01AM CST

AGIO: 94.46 (-1.51)

Agios Cancer 'Metabolism' Drug Clears Bone Marrow of Leukemic Cells
at The Street - Tue Nov 18, 5:02PM CST
The experimental drug from Agios, designed to attack the "metabolism" of cancer cells, has demonstrated early but strong clinical responses in a study involving patients with advanced leukemia.
AGIO: 94.46 (-1.51), CELG: 106.90 (-0.08)

Agios Pharmaceuticals Announces Early Phase 1 Data Showing Clinical Activity of AG-120 as a Single Agent in Advanced Acute Myeloid Leukemia (AML)
GlobeNewswire - Tue Nov 18, 5:01PM CST
-Significant Clinical Responses and Reduction of 2HG Biomarker Provide Early Validation of Mutant IDH1 as a Therapeutic Target in AML -
AGIO: 94.46 (-1.51)

Jim Cramer Says to Buy Six Flags, Avoid SeaWorld Entertainment
at The Street - Wed Nov 12, 1:20PM CST
TheStreet's Jim Cramer says investors shouldn't be tricked by SeaWorld's attractive dividend yield. Instead, stick with Six Flags Entertainment.
SEAS: 17.03 (-0.07), SIX: 39.64 (-0.48), AGIO: 94.46 (-1.51)

Biotech Weekly: When Mid Caps Are Priced Nearly For Perfection
Daniel Ward - at Seeking Alpha - Mon Nov 10, 9:28AM CST

XBI: 170.74 (+0.78), SLXP: 103.78 (+0.15), ICPT: 156.53 (+0.60), IBB: 293.63 (-0.58), AGIO: 94.46 (-1.51)

Agios Pharmaceuticals' (AGIO) CEO David Schenkein on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Sat Nov 08, 6:31AM CST

AGIO: 94.46 (-1.51)

Premarket Gainers / Losers
Seeking Alpha - at Seeking Alpha - Fri Nov 07, 8:14AM CST

BEBE: 2.55 (+0.03), ANET: 75.92 (-1.08), TKMR: 16.00 (-0.12), ORBC: 6.24 (-0.07), MDRX: 11.97 (-0.19), RMTI: 9.05 (-0.76), CTIC: 2.18 (unch), SHLD: 35.68 (+0.48), UBNT: 29.58 (+0.02), RIG: 25.75 (+0.39), KGC: 2.83 (+0.09), APT: 2.77 (+0.02), ANF: 29.40 (+0.42), MITK: 3.69 (-0.13), ZNGA: 2.69 (unch), CNET: 1.78 (-0.04), KING: 16.14 (+0.20), NETE: 1.34 (+0.03), SLXP: 103.99 (+0.36), RPRX: 8.79 (-0.08), NADL: 3.21 (+0.05), PGNX: 6.41 (+0.04), AVNR: 13.68 (+0.11), FSLR: 48.81 (-0.01), DVA: 74.93 (-0.19), NDLS: 22.28 (+0.20), ICPT: 156.53 (+0.60), AGIO: 94.46 (-1.51), PLNR: 7.27 (+0.04)

Agios Pharmaceuticals EPS of $0.10
Seeking Alpha - at Seeking Alpha - Fri Nov 07, 6:11AM CST

AGIO: 94.46 (-1.51)

Agios Pharmaceuticals posts 3Q profit
Automated Insights - Fri Nov 07, 6:09AM CST
CAMBRIDGE, Mass. (AP) _ Agios Pharmaceuticals Inc. (AGIO) on Friday reported earnings of $3.7 million, or 10 cents per share, in its third quarter.
AGIO: 94.46 (-1.51)

Agios Pharmaceuticals Reports Third Quarter 2014 Financial Results
GlobeNewswire - Fri Nov 07, 6:00AM CST
Agios Pharmaceuticals, Inc. (Nasdaq:AGIO), a leader in the fields of cancer metabolism and rare genetic disorders of metabolism, today reported business highlights and financial results for the third quarter ended September 30, 2014.
AGIO: 94.46 (-1.51)

Agios Pharmaceuticals Inc. (AGIO) Stock Research Links

AGIO Board Company Profile Buy Rating Time & Sales News Filings Financials

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

TIGR Investors Eye Class Action Amid Legal Woes

A Legal Storm Brews Over UP Fintech When it rains, it pours, and for UP Fintech Holding Limited, the sky's looking pretty stormy. Investors who jumped on the NASDAQ:TIGR bandwagon between April 2024 and June 2026 are finding themselves at the center of a nasty legal maelstrom. The allegations? Well, they're explosive, hinting at a pattern of unlicensed cross-border...

Piedmont Orthopedics Expands With Spine Expert

New Talent Joins OrthoAtlanta When a spine surgeon like Dr. Avionna L. Baldwin Jefferson heads to a practice, it becomes the kind of news that ripples through both local and medical communities. Piedmont Orthopedics | OrthoAtlanta has pulled a real coup, drawing in this fellowship-trained whiz with a sharp eye for minimally invasive procedures, craning necks in Covington,...

Porte Brown Hits #3 for Young Accountants in 2026

Fresh Faces Rank Porte Brown High Now here's a thing most big-name firms might envy—Porte Brown nabbed the #3 spot on Accounting Today's 2026 list of Best Firms for Young Accountants. This isn't some fly-by-night recognition; it speaks to their whole gig—nurturing, training, and growing young talent in the world of numbers. When you talk about setting the bar for...

Implantica's Q3 2026: A Potential Leap Forward?

Implantica Prepares to Unveil Q3 Results We're heading into the home stretch for 2026, and Implantica's about to unveil its third-quarter results. With its presentation scheduled for November 19 at 15:00 CET, this medtech outfit has caught some eyes, especially with their flagship offering, RefluxStop®. Paying attention here might be worthwhile, as this plays into a...

SoLo Alpha: Transforming Retail Investment Returns

Pushing Beyond Traditional Financial Constructs In a world where the average Joe is often left holding the short end of the investment stick, SoLo Funds comes charging through with SoLo Alpha, touting a whopping 16% annualized return. They're riding a wave of what seems like a financial revolution, serving up high returns usually reserved for the big fish. It’s hard not...

'Luz de las Naciones' Event: A Cultural Milestone

A Vibrant Showcase of Culture and Faith Grab your seatbelt, because when you hear about a cultural event lighting up the scene, especially one backed by The Church of Jesus Christ of Latter-day Saints, it means something's brewing. We're diving headfirst into 'Luz de las Naciones,' a celebration that's keeping its promise to highlight Latin America's zest and vibrant...

Fibocom & Suntek Tackle Smart Lawn Mower Market

Robotic Mowers Meet Tech Mastery In the never-ending quest to tech-up every corner of our lives, robotic mowers are carving out their patch of the market—thanks in no small part to Fibocom and Suntek teaming up like a couple of tech-savvy gardeners. Here’s the lowdown: In Munich, during the electronica 2026 show, these two companies showcased how they’re making...

Webull Faces Class Action: Investors Eye Plaintiff Role

Webull Under Fire: What's Happening? In a development that's got investors biting their nails, Webull (NASDAQ:BULL) finds itself caught up in a class action. The folks at Robbins LLP are waving a red flag, urging those who bought into Webull between the dates of April 26, 2025, and October 6, 2026, to sit up and take notice. A class action complaint claims that the...

Randi Baptiste Sets a New Standard in Youth Sports

Youth Sports: Revolutionized by Randi Baptiste In an era where youth sports face a minefield of health risks and performance pressures, Randi Baptiste stands out. This isn't just about running around the park—this is about fundamentally transforming how we think about athletic development for young folks. Recognizing Baptiste for his contributions, The Inner Circle...

Hollyland Powers APEC 2026 with Wireless Solutions

APEC 2026 Finds a Partner in Hollyland Here's a nugget for ya: Hollyland, the pride of Shenzhen in wireless audio and video solutions, is stepping into the big leagues by becoming an official sponsor for the APEC 2026 meetings. Now that's quite the homecoming parade! Given the bustling vibes of a global conference, Hollyland’s gear will play a starring role in keeping...